Reversible Z-E Isomerism and Pharmaceutical Implications for SU5416

By Sistla Anand   Shenoy Narmada  

Drug Development and Industrial Pharmacy, Vol. 31, Iss. 10, 2005-12 ,pp. : 1001-1007

Informa Healthcare

Access to resources Recommend Favorite

Oxindole Derivatives: Synthesis and Antiglycation Activity

By  

Medicinal Chemistry, Vol. 9, Iss. 5, 2013-08 ,pp. : 681-688

Bentham Science Publishers

Access to resources Recommend Favorite

A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers

By Fury Matthew   Zahalsky Andrew   Wong Richard   Venkatraman Ennapadam   Lis Eric   Hann Lucy   Aliff Timothy   Gerald William   Fleisher Martin   Pfister David  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

A phase I Study with oral SU5416 in patients with advanced solid tumors: A drug inducing its clearance

By Salzberg Marc   Pless Miklos   Rochlitz Christoph   Ambrus Klara   Scigalla Paul   Herrmann Richard  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 299-304

Springer Publishing Company

Access to resources Recommend Favorite

Design, Synthesis and Cytotoxic Activity of Spiro(oxindole-3-3'- pyrrolidine) Derivatives

By  

Letters in Drug Design & Discovery, Vol. 15, Iss. 1, 2018-01 ,pp. : 37-45

Bentham Science Publishers

Access to resources Recommend Favorite